IN EPITHELIAL CELLS, PDZ domain-containing proteins contribute to segregation of proteins, including membrane-bound transporters and ion channels, to the apical and basolateral domains of cells as well as subdomains of the plasma membrane and cell organelles (6). This segregation of transporters, channels, and pumps to apical or basolateral membranes is essential for vectoral transport of ions and solutes. Moreover, the localization of specific sets of proteins permits precise regulation of transport and signaling proteins in specialized domains such as synapses, cell junctions, and areas rich in receptors.
IN EPITHELIAL CELLS, PDZ domain-containing proteins contribute to segregation of proteins, including membrane-bound transporters and ion channels, to the apical and basolateral domains of cells as well as subdomains of the plasma membrane and cell organelles (6) . This segregation of transporters, channels, and pumps to apical or basolateral membranes is essential for vectoral transport of ions and solutes. Moreover, the localization of specific sets of proteins permits precise regulation of transport and signaling proteins in specialized domains such as synapses, cell junctions, and areas rich in receptors.
PDZ domain-containing proteins dock proteins that contain PDZ recognition sequences that have a characteristic fouramino acid (AA) sequence usually found at the COOH terminus of the protein. Intracellular localization of proteins by PDZ domains can occur via a number of mechanisms including mediating transport, retention in intracellular compartments, and retention on the plasma membrane (6) . In renal epithelial cells, various PDZ proteins localize selectively to the apical membrane (NHERF-1, NHERF-2, and PDZK1), the basolateral membrane (MINT 1, MINT 2-3, CASK, MAGI-1a, and MALS/Veli-1-3), the Golgi network (GOPC), and tight junctions and basolateral membrane (MAGI-1 and MUPP1) (6, 13, 35, 49) . Interaction of transport and signaling proteins with PDZ proteins has both physical and functional consequences. For example, in the apical membrane, NHERF-1 and -2 interact with both ROMK (Kir1.1) and CFTR, resulting in increased cell surface expression of ROMK, increased coimmunoprecipitation of ROMK with CFTR, and altered channel characteristics of ROMK (sensitivity to inhibition by glibenclamide) (56) . Interaction of NHERF-1 or -2 with the Na ϩ /H ϩ exchanger NHE3, NaP i -2a, and other transporters in a multiprotein complex brings them into association with PKA, facilitating their regulation by cAMP (6) . PDZ proteins associate with each other via PDZ domains as well as other scaffolding proteins to create networks that organize high-order protein complexes to localize them in the cell and to ensure integrated regulation of their activities (6) .
The mechanisms by which PDZ proteins localize in cells are not fully established but probably include interaction with membrane-bound proteins and chaperone proteins. Two PDZ proteins, MUPP1 and MAGI-1, normally associated with tight junctions, appear to require additional proteins for tight junctions and plasma membrane localization (10, 21, 54) . These mechanisms are important for regulating renal function, but in many cases the components and mechanisms are not fully defined. Although critical for these functions, PDZ interactions alone may not be sufficient to explain all localization phenomena (33, 46) .
Recently, we (17) found that the Ca 2ϩ -sensing receptor (CaR) interacts with and inactivates two K ϩ channels, Kir4.1 and Kir4.2. Kir4.1, probably in a complex with Kir5.1 and interacting with the PDZ protein MAGI-1a, is a component of the basolateral K ϩ conductance in the distal nephron (25, 49) . Kir4.2, an inwardly rectifying K ϩ channel that is closely related to Kir4.1, is also expressed in the distal convoluted tubule of the distal nephron and probably other nephron segments, although its membrane distribution and the full extent of its expression along the nephron are not established (31) . Kir4.2 is expressed in a number of other tissues and cell types including the central nervous system (neurons) and Calu 3 cells, an airway epithelial cell type (55) . Kir4.2 has biophysical characteristics similar to those of Kir4.1, interacts with Kir5.1, and may have functions similar to those of Kir4.1 (31, 37, 50) .
To identify proteins that interact with Kir4.2 and that could contribute to its regulation, we used the COOH-terminal 125 AA of Kir4.2 that contain a PDZ domain to screen a human kidney cDNA library using the yeast two-hybrid approach. We found that Kir4.2 interacts with a ubiquitously expressed PDZ domain-containing protein, MUPP1, in a PDZ-dependent manner but that overexpression of MUPP1 reduces cell surface expression of Kir4.2 and currents attributable to it in Xenopus oocytes. These results demonstrate that Kir4.2 interacts with MUPP1 such that MUPP1 is a potential scaffolding protein for Kir4.2.
MATERIALS AND METHODS
Materials. All chemicals were purchased from Sigma or Fisher Scientific unless specified otherwise. The SuperSignal West Pico chemiluminescent substrate and BCA protein assay reagent were obtained from Pierce. The polyclonal anti-Myc (A-14) and monoclonal anti-Myc (9E10) antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). The polyclonal anti-Kir4.2 antibody was provided by Dr. C. E. Hill (Queen's University, Kingston, ON, Canada) (14) . The monoclonal anti-CaR antibody was described previously (3) .
Yeast two-hybrid cloning. A cDNA representing the COOH-terminal 125 AA of the rat Kir4.2 (AA 250 -375) in the bait plasmid pAS2.1 was used to screen a human adult kidney cDNA library in pACT2 (Invitrogen). The bait plasmid was transformed into Saccharomyces cerevisiae strain AH109 by electroporation, mated with the pretransformed library in S. cerevisiae strain Y187, and then plated on medium deficient in leucine, tryptophan, and histidine (triple dropout medium) (3, 17) . The plates were replicated on medium lacking histidine, tryptophan, leucine, and adenine (quadruple dropout medium). The colonies that grew under these conditions were tested for ␤-galactosidase activity. Yeast expressing the library plasmid pACT2 without an insert and the pACT2 vector with ␤-galactosidase were used as controls. The positive colonies were analyzed further by purifying the plasmids and sequencing the inserts from either end. The cDNA sequences were analyzed by searching the GenBank data base for homology to known DNA sequences. These positive clones were mated with the Kir4.2 construct plated on medium lacking histidine, leucine, tryptophan, and adenine to confirm the interaction.
Construction of plasmids. To investigate the relationship between Kir4.2 and Kir5.1, without the limitation of specific antibodies, we made Myc-and hemagglutinin (HA)-tagged constructs of each channel, engineering epitope tags into the NH 2 terminus of the proteins. The cDNA coding for rat Kir4.2 (Kir4.2) was a generous gift from Dr. C. E. Hill (14) . The Kir4.2pGem construct was digested with EcoRI and NotI and then ligated into EcoRI and NotI sites of pCruz-HA or pCruz-Myc vector. The cDNA coding for rat Kir5.1 (Kir5.1) was generously provided by Stephen Tucker (University Laboratory of Physiology, Oxford, UK) (38) . The Kir5.1pBF construct was digested with ApaI, blunt ended, and then digested with KpnI. The pCruz-Myc or -HA constructs were digested with NotI, blunt ended, and then digested with KpnI. The fragments were ligated into pCruz-Myc or pCruz-HA vector. All cDNA constructs were verified by direct sequencing. FLAG-tagged MUPP1 was generously provided by Dr. David Clapham (Harvard University, Cambridge, MA) (23) .
Preparation of anti-MUPP1 antibodies. Rabbit polyclonal antibodies were made using a peptide from the 210-AA region of MUPP1 between PDZ domains 5 and 6 (AA 780 -793: PLSPEEGYVSAKED) (51) . The sequence of this peptide is conserved in the human, mouse, rat, dog, and cow proteins, and it does not show significant homology to other proteins in the National Center for Biotechnology Information protein database. Two rabbits were injected. Specificity of the antisera was demonstrated as follows: 1) the sera from both rabbits recognized the same 220-kDa protein; 2) both sera recognized the FLAGtagged MUPP1 expression construct from Dr. David Clapham (23); and 3) preincubation of the antisera with the antigenic peptide blocked recognition of native and expressed MUPP1.
Transfection, immunoblotting, immunoprecipitation, and cell surface biotinylation. Human embryonic kidney (HEK)-293 cells were transiently transfected with the epitope-tagged channel constructs indicated (HA-tagged Kir4.2pCruz, Myc-tagged Kir4.2pCruz, HAtagged Kir5.1pCruz, Myc-tagged Kir5.1pCruz, CaRpcDNA3, or FLAG-tagged MUPP1) using the FuGene 6 reagent and were incubated at 37°C for 24 -48 h. The medium was removed and washed once with 1ϫ PBS. The cells were lysed with 1ϫ RIPA buffer, and the lysates were centrifuged at 15,000 rpm for 1 h at 4°C. The protein concentrations in the cell lysates were determined using the BCA protein assay reagent with BSA as a standard and were then adjusted to the same concentration with buffer. The samples were subjected to 11% SDS-PAGE and processed for immunoblotting, and the levels of protein expression were determined. The cell lysates were used for coimmunoprecipitation as described previously (16) . Briefly, a monoclonal anti-FLAG, a polyclonal anti-Myc (A-14), our rabbit anti-MUPP1, or an anti-Kir4.2 antibody (Dr. C. E. Hill) was separately loaded onto the Dynabead-protein A complex and slowly rotated for 2 h (17). The antibody-loaded Dynabead-protein A complex was rinsed twice, and the beads were mixed with the various cell lysates, and rotated in the cold room overnight. The supernatants were discarded, and the Dynabead-protein A complex was washed. Loading buffer was added and vortexed vigorously. The tubes were placed in Dynal-MPC to collect the sample buffer. The samples were heated at 55°C for 20 min and then subjected to SDS-PAGE for immunoblotting using the antibodies indicated. For coimmunoprecipitation studies using rat kidney cortex membrane extracts, rat kidneys were isolated and decapsulated. The cortex was separated from the medulla, cut to small pieces, and homogenized in a buffer containing 20 mM HEPES, pH 8.0, 2 mM MgCl 2, 1 mM EDTA, and protease inhibitors and centrifuged at 2,000 rpm for 10 min. The supernatant was centrifuged at 13,500 rpm for 60 min to obtain crude membrane and cytosol fractions. The samples were used for immunoblotting to confirm the presence of the endogenous proteins. The crude membranes were extracted in 1ϫ RIPA buffer for 60 min and centrifuged at 13,500 rpm for 60 min, the resulting supernatants were used for immunoprecipitation with the anti-MUPP1 or anti-Kir4.2 antibodies, and the immunoprecipitated samples were processed for immunoblotting using antibodies against MUPP1 and Kir4.2 (17) . Peptide blocking of antiserum was performed by incubating MUPP1 or Kir4.2 antiserum at a 1:500 dilution with 50 g/ml of the antigenic peptide for 3 h in blotto at 4°C before incubation with the blots. Cell surface expression of Kir4.2 was measured using cell surface biotinylation. Cells are washed with PBS and incubated with sulfo-NHS-SS-biotin (biotin; 0.5 mg/ml) for 5 min on ice. The cells are washed three times with PBS, quenched with 100 mM glycine in PBS for 5 min, dissolved in immunoprecipitation buffer (125 mM NaCl, 62.5 mM NaH2PO4, pH 7.2, 0.625% lubrol, and protease inhibitors), and incubated overnight with avidin-agarose. The agarose-bound complexes are precipitated and size-fractionated by SDS-PAGE, and proteins were identified by immunoblotting (12) .
Immunocytochemistry. Xenopus oocytes were injected with H2O or cRNAs coding for MUPP1 and Kir4.2 as indicated. On the second day after injection, the oocytes were fixed in 4% formaldehyde for 1 h followed by 100 mM glycine in PBS for 30 min. They were stored in 30% sucrose and frozen in liquid nitrogen overnight, after which 10-m cryostat sections were cut. The sections were blocked in 10% donkey serum, 1% BSA, and 0.1% Tween 20 in PBS for 1 h. Oocytes stained with only the secondary antibody were served as controls. Rabbit polyclonal anti-Kir4.2 antibody was used at a dilution of 1:100 overnight, followed by incubation with a secondary anti-rabbit Cy3 antibody at a dilution of 1:1,000. Sections were observed using fluorescent microscopy (Zeiss Axiovert 200), and images were collected using the AxioVision program (Zeiss).
Preparation of Xenopus oocyte membranes. Eight to ten oocytes were suspended in Tris buffer (5 mM Tris, pH 8, 1 mM EDTA, and 1 mM EGTA) and disrupted by passage through a 25-gauge needle. The suspension was centrifuged at 1,200 g. The lipids were removed from the top of the tube, and the fraction containing the membranes and cytosol was removed and centrifuged at 15,000 g to separate membrane and cytosolic fractions.
Electrophysiology. Oocytes were harvested and prepared as previously described (41). Kir4.2 and Kir4.2⌬PDZ were subcloned into the oocyte expression vectors, pGEMSH. Linearized plasmids were used for in vitro cRNA synthesis. Forty-six nanoliters of H 2O or cRNA mixtures were injected into stage VI oocytes (Kir4.2 at 5 ng and MUPP1 at either 2.5 or 10 ng). Oocytes were studied 1-5 days after cRNA injection. We voltage-clamped oocytes to 0 mV in a K ϩ Ringer (98 mM KCl, 1.0 mM CaCl2, 1.0 mM MgCl2, and 5 mM HEPES, pH 7.5). Since intracellular [K ϩ ] is 80 -90 mM (Romero MF and Boron WF, unpublished observations), this high-K ϩ solution results in a slightly inward chemical gradient for K ϩ and a reversal potential near 0 mV. From 0 mV, oocytes were stepped by 20 mV from Ϫ120 to ϩ80 mV using 75-ms voltage pulses. Current-voltage curves were generated by averaging the final 10 ms of each resulting current response as previously described (11, 41) .
RESULTS

Interaction of MUPP1 with Kir4.2 in yeast.
Based on our finding that the CaR interacts with the inwardly rectifying K ϩ channel Kir4.2 and that the COOH terminus of Kir4.2 contains a class I PDZ binding domain, we screened an adult human kidney cDNA library using the yeast two-hybrid system to identify additional proteins that interact with the channel and that could form additional parts of a signaling complex controlled by the CaR. With the COOH-terminal 125 AA of Kir4.2 as bait, we identified two cDNAs that code for MUPP1 (multi-PDZ protein 1), a ubiquitously expressed protein that contains 13 tandem PDZ binding domains ( Fig. 1) (51) . We did not identify other PDZ domain-containing proteins in this screen of Ͼ4 ϫ 10 6 cDNA clones. MUPP1 is 2,054 AA in length, with a molecular mass of ϳ220 kDa (44, 51) . Our clones were partial, beginning in the predicted seventh PDZ domain at AA 1154 and 1160 (nt 3506 and 3494) and extending through the COOH terminus (AA 2054, nt 6173) so that they are ϳ900 AA in length (Fig. 1A) (51) . Sequencing revealed that these clones are identical to the sequences in GenBank. The COOH-terminal 900 AA of MUPP1 include part of PDZ domain 7 and PDZ domains 8 -13.
These results indicate that Kir4.2 interacts with PDZ domains 8 -13, although it also could interact with PDZ domains 1-7, since these were not specifically tested. To identify other proteins with which MUPP1 could interact and characterize the selectivity of its interaction with Kir4.2, we tested the COOHterminal 125 AA of Kir5.1, another K ϩ channel expressed in the distal nephron with a COOH-terminal PDZ sequence (ESQM), and the COOH-terminal 210 AA of the CaR that contain two potential internal PDZ sequences (RSNV AA 891-894 and QSTV AA 1060 -1063) in the yeast two-hybrid assay (7). Clonal yeast strains (AH109) containing the cDNAs corresponding to the COOH termini of these proteins in the bait plasmid pAS2.1 were mated with the yeast strain Y187 containing the MUPP1 clone isolated from the cDNA library. The yeast from these matings were plated on quadruple dropout-selective medium, and interactions were identified by the yeast that survived. .2) , duplicate samples were immunoprecipitated with the Kir4.2 Ab; and in the right lanes (IP MUPP2), duplicate samples were immunoprecipitated with the MUPP1 Ab. The top panel is from an 11% gel and was blotted with the anti-MUPP1 Ab; the bottom panel is from a 6% gel (necessary to separate Kir4.2 from the IgG heavy chain) and was blotted with the anti-Kir4.2 Ab. The Kir4.2 bands are more fuzzy than normal because of the 6% gel. The positions of MUPP1 and Kir4.2 were determined by size and the position of these proteins expressed in HEK-293 cells and run in separate lanes. D: specificity of the Kir4.2 Ab in rat kidney extracts determined using peptide blocking as described for the MUPP1 Ab. The samples containing Kir4.2 or Kir5.1 were immunoprecipitated with a polyclonal anti-Myc antibody, and the immunoprecipitates were immunoblotted with an anti-FLAG antibody to detect MUPP1-FLAG. The samples containing the CaR were immunoprecipitated with the anti-CaR antibody and then immunoblotted with the anti-FLAG antibody to recognize MUPP1. Figure 2 shows that Kir4.2 coimmunoprecipitated with MUPP1 but that Kir5.1 and the CaR did not. Figure 2 also shows that the immunoprecipitation antibodies in fact isolated their target proteins. These results demonstrate that MUPP1 interacts with Kir4.2 but not with Kir5.1 or the CaR in mammalian cells. We also tested NBCe1 (a sodium-dependent bicarbonate transporter) and WTIP (Wilms tumor-interacting protein), two other proteins with COOH-terminal PDZ domains, but they did not coimmunoprecipitate with MUPP1 (not shown), demonstrating that the interaction of Kir4.2 with MUPP1 is selective in mammalian cells. Figure 3 shows that the interaction of Kir4.2 with MUPP1 in reciprocal coimmunoprecipitation assays depends on the COOH-terminal four AA of the channel, its PDZ binding domain (QSNV). cDNAs coding for Myc-tagged wild-type Kir4.2 (Kir4.2-myc) and Myc-tagged Kir4.2 with deletion of the four COOH-terminal AA (Kir4.2⌬PDZ-Myc) were coexpressed in HEK-293 cells with MUPP1. The Kir4.2⌬-Myc construct did not coimmunoprecipitate with MUPP1 efficiently whether the anti-MUPP1 antibody or the anti-Myc antibody (directed at Kir4.2) was used. A small amount of Kir4.2⌬PDZ-Myc seen in the coimmunoprecipitation with the MUPP1 antibody may be due to interaction of MUPP1 with additional regions of the channel and the efficiency of immunoprecipitation of the expressed MUPP1-FLAG and the endogenous MUPP1 (52) . Similar amounts of MUPP1 and Kir4.2-myc or Kir4.2⌬PDZ-Myc were immunoprecipitated in all lanes and extracts.
To study MUPP1 in native tissues, we produced a rabbit polyclonal antibody to MUPP1 directed at a region between PDZ domains 5 and 6 (AA 780 -793). This region is conserved in mouse, human, rat, dog, and cow proteins. Figure 4 shows that the antibody recognized a 220-kDa protein in extracts from kidney cortex and medulla and in HEK-293 cells (A) and in Xenopus oocytes (B). In the extracts from the mammalian cells, a predominant band was seen at ϳ220 kDa, and a lower band at ϳ130 kDa was also seen only in the samples from rat kidney. The majority of the signal in the lower band was blocked by incubation with peptide. The identity of the 130-kDa band is not certain, but it could represent either a splice variant or a proteolytic product. A band of this size in kidney has been reported by others (44) . Similar findings were obtained with antiserum from a second rabbit (not shown).
MUPP1 and Kir4.2 coimmunoprecipitated reciprocally from rat kidney cortex extracts as shown in Fig. 4C . In the first lanes for both proteins, the immunoprecipitation was carried out with agarose beads but without attached immunoprecipitation antibody. The next two lanes show duplicate samples where the Kir4.2 antibody was used to immunoprecipitate proteins from the rat kidney extract, and in the last two duplicate lanes, the MUPP1 antibody was used. The top panel was immunoblotted with the anti-MUPP1 antibody, and the bottom panel was blotted with the Kir4.2 antibody. Both antibodies immunoprecipitated their targets, and the targets isolated their partners. As would be expected, the bands representing the immunoprecipitation target proteins, MUPP1 (top right) and Kir4.2 (bottom left) are denser than those representing the partner proteins [MUPP1 (top left) and Kir4.2 (bottom right)], because some proportion of the immunoprecipitation target proteins did not interact with the partners we were studying. Figure 4D shows that the anti-Kir4.2 antibody recognized a specific band in rat kidney extracts. Coexpression of MUPP1 and Kir4.2-Myc resulted in reduced cell surface expression of Kir4.2-Myc, as shown in Fig. 5 . With increasing expression of MUPP1, the amount of Kir4.2 reaching the cell surface was progressively reduced. These results indicate that Kir4.2 interacts with MUPP1 in a PDZ-dependent manner, that the interaction of Kir4.2 with MUPP1 is selective, and that increased expression of MUPP1 leads to reduced levels of Kir4.2 at the cell surface.
Functional consequences of coexpression of MUPP1 and Kir4.2 channels in Xenopus oocytes. To determine whether the interaction of Kir4.2 with MUPP1 affects inwardly rectifying K ϩ currents, we coexpressed the two proteins in Xenopus oocytes and measured whole cell currents. As shown in Fig. 6 , A and B, increasing amounts of injected MUPP1 cRNA decreased whole cell currents. Injection of 5 ng of cRNA coding for Kir4.2 resulted in maximum K ϩ currents, ϳ2.5 A at Ϫ80 mV. Coinjection of 2.5 ng of MUPP1 cRNA resulted in an ϳ60% reduction in current. In oocytes injected with 10 ng of cRNA, currents were reduced to a degree similar to those with 2.5 ng of MUPP1 cRNA. In individual experiments, the reduction appeared greater with 10 ng of MUPP1, but the difference was not statistically significant. Expression of Kir4.2⌬PDZ (failed to interact with MUPP1, see Fig. 3 ) resulted in lower currents than an equivalent amount of Kir4.2, indicating that the PDZ domain is important for channel function. However, in contrast to Kir4.2, expression of MUPP1 had no significant effect on currents attributable to Kir4.2⌬PDZ (Fig. 6, A and B ). Figure 6C shows the level of Kir4.2 expression in oocyte membranes and the effects of MUPP1 coexpression under the conditions used for the electrophysiological studies. Increasing MUPP1 expression corresponded to reduced oocyte membrane expression of Kir4.2, consistent with the reduction in whole cell currents, as corroborated in Fig. 7 . Kir4.2⌬QSNV is present in the oocyte membranes, and the level of MUPP1 expression did not affect its level of expression. The presence of Kir4.2⌬QSNV protein in the membrane fraction does not mean that it is functional or at the cell surface, because it may be present in a submembrane vesicle compartment (Kleyman TR and Frizzell RA, personal communication). These results clearly demonstrate that the effects of MUPP1 on localization and function of Kir4.2 require its PDZ domain. These results are corroborated by immunofluorescent staining of sections of Xenopus oocytes for Kir4.2 ( Fig. 7) that show progressive loss of membrane staining for Kir4.2 with coexpression of increasing amounts of MUPP1. Oocyte sections were stained for either Kir4.2 or MUPP1. In the absence of MUPP1 injection, Kir4.2 is shown as bright staining at the membrane. With increasing MUPP1 injection, Kir4.2 staining at the membrane becomes less prominent. With injection of 10 ng of MUPP1 cRNA, membrane staining of Kir4.2 is difficult to see, consistent with the absence of Kir4.2 currents seen under the same conditions. The MUPP1 antibody recognized the endogenous protein (MUPP1; Fig. 4 ), but the staining also increased with increasing amounts of MUPP1 cRNA injected. These results suggest that under these experimental conditions, MUPP1 prevents Kir4.2 from reaching the cell surface in a form that it is functional. Fig. 6 . Coexpression of Kir4.2 and MUPP1 leads to reduced whole cell currents in Xenopus oocytes. Xenopus oocytes were injected with H2O (control), Kir4.2 (5 ng), Kir4.2 (5 ng) and MUPP1 (2.5 ng), Kir4.2 (5 ng) and MUPP1 (10 ng), Kir4.2⌬QSNV (5 ng), or Kir4.2⌬QSNV (5 ng) and MUPP1 (10 ng). Electrophysiological studies were performed 2 days after injection. Two-electrode voltage clamp was used to measure whole oocyte currents. Oocyte membranes were voltage clamped to 0 mV and pulsed for 75 ms between Ϫ120 and ϩ80 mV. A: current-voltage (I-Vm) plot of oocytes resulting from the basal currents of Kir4.2 with MUPP1 as shown. B: summary data showing Kir4.2 currents at Ϫ80 mV for each condition [Kir4.2, n ϭ 8; Kir4.2 and MUPP1 (2.5 ng), n ϭ 6; Kir4.2 5 and MUPP1 (10 ng), n ϭ 5; Kir4.2⌬QSNV (5 ng), n ϭ 5; or Kir4.2⌬QSNV and MUPP1 (10 ng), n ϭ 3, where n indicates the number of oocytes studied and represents separate injections and studies on separate days]. The currents in the oocytes expressing Kir4.2 alone were statistically different from the other conditions, but the currents in the oocytes expressing Kir4.2 and MUPP1, Kir4.2⌬QSNV, and MUPP1 were statistically indistinguishable. C: expression of Kir4.2 or Kir4.2⌬PDZ in oocytes. Western blots were performed with 3 sets of pooled oocytes (n ϭ 8 -12) from separate injections. A representative Western blot for Kir4.2 is shown at top, and the bar graph (bottom) shows summary data for Kir4.2 expression (n ϭ 3).
DISCUSSION
Many membrane-bound transporters and ion channels contain COOH-terminal PDZ sequences that permit their localization and organization in specific plasma membrane domains by PDZ domain-containing proteins. In many cases, the interaction of a transporter or channel with a PDZ protein results in increased cell surface expression and activity (6, 15, 34, 42, 43, 45, 48, 56) . In the kidney, the PDZ proteins responsible for basolateral distribution of K ϩ channels are not fully characterized. MALS/Veli/Lin-7b leads to basolateral localization of Kir2.3, and MAGI-1a interacts with the Kir4.1/Kir5.1 heterodimer in the distal nephron (25, 34, 39) . In addition to Kir2.3, Kir4.1, and Kir5.1, both Kir4.2 and Kir7.1 are also localized in the distal nephron (8, 18, 31, 34, 36, 47) . The precise distribution of Kir4.2 in the distal nephron is not defined due to lack of appropriate antibodies, although it is clearly present in the distal convoluted tubule based on RT-PCR of microssected tubules (31) . The additional proteins with which it interacts and that localize it in the cell are not known.
On the basis of yeast two-hybrid cloning and co-immunoprecipitation studies, we found that Kir4.2 interacts selectively with MUPP1, a ubiquitously expressed PDZ protein. The interaction probably involves one or more of PDZ domains 8 -13 but also could involve domains 1-7. In our screen of the human kidney cDNA library, we did not identify other PDZ domain-containing proteins, a result that does not prove that Kir4.2 cannot interact with other PDZ domain-containing proteins (it does interact with CIPP, a central nervous systemspecific PDZ protein) but suggests that in the kidney, Kir4.2 may preferentially interact with MUPP1 (24) . The ability to coimmunoprecipitate Kir4.1 and MUPP1 from kidney cortex extracts suggests that this interaction may take place in vivo, although the interaction in this setting could occur as a result of the homogenization and extraction procedure. The interaction is selective, because Kir5.1, NBCe1, and WTIP (a podocyte slit diaphragm protein), all proteins that contain COOH-terminal PDZ sequences, do not coimmunoprecipitate with MUPP1. Kir4.1 and Kir4.2 both form heterodimers with Kir5.1 (26, 38) . Kir4.1, expressed on the basolateral membrane of the distal nephron, interacts with MAGI-1a. Through this interaction, Kir4.1 may interact with a unique set of additional proteins, although sequences within Kir4.1 and Kir5.1 are sufficient for heterodimerization (22, 25, 49) . Through its interaction with MUPP1, Kir4.2 may interact with a different set of proteins from Kir4.1, may be subject to different modes of regulation, or may be found in different subdomains of epithelial cells. The interaction of Kir4.2 with MUPP1 affects membrane currents attributable to the channel through cell surface expression under the conditions of our studies. These results suggest that through interactions with MUPP1, Kir4.2 may contribute to the basolateral K ϩ conductance. MUPP1 is a large (2054 AA, 220 kDa) protein that contains an NH 2 -terminal L27 motif and 13 PDZ domains that bind a number of proteins including other scaffolding proteins (PSD-95), viral oncoproteins, receptors, other signaling molecules, and tight junction proteins, particularly claudins (1, 4, 5, 9, 13, 21, 23, 32, 40) . Presumably, MUPP1 organizes these proteins into specific complexes affecting cell surface expression and function. In the kidney, particularly the medulla, expression of MUPP1 RNA and protein are increased by hypertonicity. Reduction in MUPP expression is associated with reduced transepithelial resistance, indicating a role for it in tight junction function (27) . MUPP1 is found in tight junctions, postsynaptic densities, and Schwann cell incisures (related to tight junctions) and associates with the plasma membrane (5, 13, 23, 29) . In polarized Madin-Darby canine kidney and inner medullary collecting duct cells (IMCD), it is present not only in tight junctions but also the lateral borders of cells (13, 27, 28) . MUPP1 has a similar domain structure and overlapping and distinct functions with another tight junction protein, Patj (1) .
This pattern of MUPP1 expression is similar to that in initial descriptions of MAGI-1a, which has a tight junction and basolateral distribution and interacts with the Kir4.1-Kir5.1 heterodimer in the distal nephron (19, 49) . MAGI-1 has a submembrane localization and requires additional proteins for tight junction localization, at least one of which is endothelial cell-selective adhesion molecule (ESAM) (19, 20, 54 ). MUPP1 appears to behave in a similar manner. We found that it is membrane associated but that the majority is cytosolic in HEK-293 cells (Huang C and Miller RT, unpublished results). In addition, in one situation, MUPP1 requires the coxsackievirus and adenovirus receptor (CAR) for membrane and tight junction localization, whereas in another, it requires claudin-4 (28) . When CAR expression in Caco-2 cells was knocked down with small interfering RNA, MUPP1 was not membrane associated and was found in cytoplasmic aggregates (10, 53) . Under some circumstances, Patj, a protein with similar structure and function, also requires additional proteins for tight junction association (1) .
All the cells we studied, including Xenopus oocytes, have significant basal levels of MUPP1 that appear to permit cell surface expression of Kir4.2. Our finding that overexpression of MUPP1 in HEK-293 cells and Xenopus oocytes reduces Kir4.2 cell surface expression and Kir4.2 currents suggests that the expressed MUPP1 is binding the expressed Kir4.2 and preventing it from reaching the cell surface. This situation is different from that of other PDZ proteins including hLin7b, CIPP, PSD-93␦, and PSD-95 and their partner membrane proteins (15, 24, 30, 34) . TIP-1, essentially a single PDZ domain, appears to function as a true scaffold antagonist (2) .
One possibility to explain this unusual effect of MUPP1 is that additional proteins or cell structures required for cell surface localization are absent or present in insufficient quantities in the two cell types we studied, HEK-293 cells and Xenopus oocytes, so that coexpression of MUPP1 with Kir4.2 does not result in increased cell surface expression of the channel. HEK-293 cells and Xenopus oocytes could lack structures such as tight junctions that result in localization of MUPP1 in a manner that permits it to increase cell surface expression of proteins with which it interacts, such as Kir4.2. An additional possibility is that binding sites for MUPP1 at the plasma membrane are saturated with endogenous protein and that additional expressed MUPP1 with Kir4.2 cannot reach sites that result in functional cell surface expression of Kir4.2. In EpH4 cells, a mammary epithelial cell line, endogenous Patj and MUPP1 appear to require their NH 2 -terminal L27 domains for localization in tight junctions, because overexpression of these domains displaces the proteins. Overexpression of either MUPP1 or Patj protein can displace the other from tight junctions (1). These results suggest that a limited number of "binding sites" may be available for these two proteins in polarized epithelial cells and also, possibly, in nonpolarized cells. This observation by Adachi et al. (1) is compatible with our findings that overexpression of MUPP1 "removes" Kir4.2, possibly bound to endogenous or previously expressed MUPP1, from a cell location where the channel is active or blocks the channel's access to a site where it can be active so that in the absence of free MUPP1 binding sites, the channel does not reach the cell surface and is inactive.
In the setting of hypertonicity, when the level of expression of MUPP1 increases substantially (up to 10-fold in IMCD3 cells, perhaps analogous to our overexpression of the protein), it may displace preexisting MUPP1 or other proteins such as Patj from their sites in tight junctions or lateral cell borders (1, 27) . In the case of Kir4.2, the result could be to reduce the K ϩ conductance of the lateral cell border, an effect that would be advantageous to a cell trying to preserve its intracellular solutes and volume.
Our data demonstrate that Kir4.2, a K ϩ channel that is expressed in the distal convoluted tubule and possibly other regions of the renal cortex, interacts selectively with MUPP1, a PDZ protein with 13 PDZ domains that is present in tight junctions and lateral cell borders in renal epithelial cells. MUPP1 is of great interest because it is the type of protein that could organize Kir4.2 with other transport and signaling proteins that contain COOH-terminal PDZ domains such as CaMKII, PLC, receptors, and proteins that regulate small GTP-binding proteins into a complex to permit coordinate and precise control of their activities. The identities of the additional proteins that bind MUPP1 in the kidney, particularly the distal convoluted tubule, where Kir4.2 is expressed, are not known. In addition, all of the factors that contribute to the cellular localization of MUPP1 remain to be identified. Despite the fact that the picture of how the CaR, Kir4.2, and MUPP1 interact is incomplete at this time, understanding how these proteins interact and identifying additional members of the complex will contribute to an understanding of the regulation of distal nephron ion transport.
